JNJ vs MRK
By Alex · Tickerpine
Johnson & Johnson vs Merck & Co., Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | MRK |
|---|---|---|
| Price | $273.14 | $156.45 |
| Market cap | $658.24B | $385.99B |
| P/E ratio | 31.7 | 120.3 |
| ROE | 25.74% | 6.96% |
| Profit margin | 21.48% | 4.77% |
| Revenue growth | 6.60% | 5.10% |
| Dividend yield | 1.96% | 2.26% |
| Beta | 0.23 | 0.21 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs MRK in plain English
- JNJ is the bigger company — about 1.7× the market cap of MRK.
- JNJ is cheaper on earnings (P/E 31.7 vs 120.3).
- JNJ earns a higher return on equity (26% vs 7%).
- JNJ is growing revenue faster (7% vs 5%).
- MRK has the higher dividend yield (2.26% vs 1.96%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.